Clinical Implications and Management of Low Hemoglobin A1c

Understanding Low HbA1c Values

In diabetic patients, an HbA1c below 6% may represent excellent glycemic control, but could also indicate frequent hypoglycemic episodes or an underlying condition affecting red blood cell turnover, as recommended by the American Diabetes Association 1, 2
Low HbA1c values (<6.5%) without hypoglycemia in patients with long life expectancy do not require deintensification of therapy, according to the American Diabetes Association 3

Recent blood transfusions can cause falsely low HbA1c values, as noted by the American Diabetes Association 4
In diabetic patients, very low HbA1c may indicate risk for hypoglycemia, especially in those with advanced age, as reported by the American College of Physicians 5
The American Society of Nephrology recommends that chronic kidney disease be considered a risk factor for hypoglycemia in diabetic patients with very low HbA1c 6
Multiple comorbidities can increase the risk of hypoglycemia in diabetic patients with very low HbA1c, as noted by the American College of Physicians 7
The use of insulin or sulfonylureas can increase the risk of hypoglycemia in diabetic patients with very low HbA1c, according to the American Diabetes Association 8

The American Diabetes Association recommends assessing for hypoglycemic episodes, especially in high-risk populations, and considering continuous glucose monitoring (CGM) to evaluate for glycemic variability and undetected hypoglycemia 4, 9
For patients with HbA1c <6.5% and evidence of hypoglycemia, the American College of Physicians recommends considering deintensification of therapy, especially in older adults or those with limited life expectancy 4
The American Diabetes Association suggests adjusting medication regimens to reduce hypoglycemia risk while maintaining reasonable control, especially in patients with advanced age or multiple comorbidities 5, 7

The American Diabetes Association recommends using CGM metrics rather than HbA1c alone for glycemic assessment in diabetic hemodialysis patients 4
Lower HbA1c targets (<7%) are appropriate for many children and adolescents with diabetes, as recommended by the American Diabetes Association 10

The American Diabetes Association recommends correlating HbA1c with blood glucose measurements and considering CGM to obtain time in range, time below range, and glycemic variability data 4, 3
For diabetic patients with appropriately low HbA1c, the American Diabetes Association suggests continuing current management if no hypoglycemia and patient has good quality of life, and monitoring for development of hypoglycemia unawareness 1, 9, 8

The American Diabetes Association states that while A1C targets below 7 % are suitable for many patients, an A1C of 4.7 % does not confer additional microvascular benefit and instead raises the risk of hypoglycemia‑related harm. 11

Clinicians should aim to adjust diabetes regimens to reach an A1C between 6.5 % and 7.5 %, a range that optimizes microvascular protection while minimizing the danger of hypoglycemia. 11